Education
About Us
Working with TipRanks
Follow Us
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
2315 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
HK$21
Hold
3.45%
Upside
Reiterated
06/24/25
The stock score is primarily supported by strong financial performance, driven by significant revenue growth and improved profitability. Technical analysis suggests a strong upward trend, although the high P/E ratio indicates potential overvaluation. The absence of a dividend yield and earnings call data slightly detracts from the overall score.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
HK$21
Hold
3.45%
Upside
Reiterated
06/24/25
The stock score is primarily supported by strong financial performance, driven by significant revenue growth and improved profitability. Technical analysis suggests a strong upward trend, although the high P/E ratio indicates potential overvaluation. The absence of a dividend yield and earnings call data slightly detracts from the overall score.
2315 Analyst Recommendation Trends
Rating
Aug 23
Jun 25
Strong Buy
0
0
Buy
1
1
Hold
0
3
Sell
0
0
Strong Sell
0
0
total
1
4
Each month's total comprises the sum of three months' worth of ratings.
2315 Stock Forecast FAQ
What is HK:2315’s average 12-month price target, according to analysts?
Based on analyst ratings, Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s 12-month average price target is 24.00.
What is HK:2315’s upside potential, based on the analysts’ average price target?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H has 18.23% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H a Buy, Sell or Hold?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s share price target?
The average share price target for Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H is 24.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$24.00 ,and the lowest forecast is HK$24.00. The average share price target represents 18.23% Increase from the current price of HK$20.3.
The highest analyst share price target is HK$24.00 ,and the lowest forecast is HK$24.00. The average share price target represents 18.23% Increase from the current price of HK$20.3.
What do analysts say about Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H?
To buy shares of HK:2315, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.